International journal of clinical pharmacology and biopharmacy (Int J Clin Pharmacol Biopharm)

Journal PubWeight™ 133.12‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics. 1979 2.07
2 The influence of temperature of ingested fluid on stomach emptying time. 1977 1.53
3 [First experiences with BS 100-141, a new antihypertensive substance]. 1976 1.51
4 Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine. 1978 1.50
5 Assessment and treatment of abstinence in the infant of the drug-dependent mother. 1975 1.49
6 Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. 1978 1.20
7 Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man. 1977 1.19
8 Clofibrate and enzymatic induction in man. 1978 1.18
9 Immune reactions associated with practolol therapy. 1978 1.12
10 Pharmacological evaluation of YC-93, a new vasodilator, in healthy volunteers. 1977 1.10
11 The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. 1975 1.04
12 Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. 1978 1.03
13 Effects of sex hormones on oncogenesis in rat urinary bladder by N-butyl-N-(4-hydroxybutyl)-nitrosamine. 1977 1.00
14 Deaths in connection with chlormethiazole (heminevrin) therapy. 1976 1.00
15 The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin. 1979 0.99
16 A clinical trial with nomifensin, a new antidepressant drug. 1975 0.98
17 [The propagation of aminoglycoside transferases in gram negative bacteria]. 1979 0.97
18 The pharmacokinetics of dihydroergotamine in the beagle. 1978 0.97
19 Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. 1979 0.97
20 Antihypertensive effect of trimepranol, a new beta-blocking agent. 1978 0.96
21 Assessment of beta-blocking activity of trimepranol in man. 1978 0.96
22 Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function. 1977 0.95
23 Intramuscular absorption of dihydroergotamine in man. 1978 0.95
24 Hormonal regulation of drug metabolism during pregnancy. 1975 0.94
25 Plasma concentrations of diazepam and its metabolites after peroral, intramuscular, and rectal administration. Correlation between plasma concentration and sedatory effect of diazepam. 1975 0.93
26 Experimentally induced pain: measurement of pain threshold and pain tolerance using a new apparatus for electrical stimulation of the skin. 1977 0.93
27 Comparison of renal excretion of chloramphenicol in patients with chronic pyelonephritis, glomerulonephritis and polycystic kidneys. 1976 0.92
28 Some aspects of pharmacokinetic and biotransformation differences in humans and mammal animals. 1978 0.92
29 Interindividual differences of protein binding in man. 1979 0.91
30 A study of practolol elimination in all grades of chronic renal failure. 1975 0.90
31 Effects of tetrahydrocannabinol on arterial and intraocular hypertension. 1979 0.90
32 Factors affecting the bioavailability of phenytoin. 1977 0.90
33 Urinary excretion of drugs in chronic renal impairment with respect to changes their tubular handling by residual nephrons. 1976 0.90
34 Increasing threat to man as a result of frequently uncontrolled and widespread use of various drugs. 1975 0.90
35 The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid-dependent asthmatics. 1977 0.89
36 Beta-lactamases. 1979 0.89
37 Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man. 1975 0.88
38 Dissociation between clinical and exercise responsiveness to beta-blockade in angina. 1978 0.88
39 Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in man. 1976 0.88
40 Effects of tolmetin, paracetamol, and of two combinations of tolmetin and paracetamol as compared to placebo on experimentally induced pain. A double blind study. 1979 0.88
41 Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours. 1976 0.87
42 Respiratory and circulatory interactions of salbutamol and theophyllamine in asthmatic patients. 1979 0.87
43 Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure. 1977 0.87
44 Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. 1975 0.86
45 Dosage monitoring through measurement of serum level--a task of clinical pharmacology. 1978 0.86
46 A clinical trial of intravenous bleomycin in the treatment of brain tumors. 1975 0.86
47 Investigation on the serum and lung tissue level of rifampicin in man. 1976 0.86
48 Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients. 1978 0.86
49 Production of endogenous D-glucaric acid and oxidative N-demethylation of amidopyrine in man: lack of correlation. 1979 0.86
50 [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital]. 1976 0.86
Next 50